The Gulf state is registering the vaccine from Chinese state pharmaceutical giant Sinopharm, for which it approved emergency use in September.
The United Arab Emirates (UAE) Ministry of Health has said that an interim review of the country’s phase three clinical trials of Chinese-made Sinopharm’s COVID-19 vaccine has an 86% effectiveness against the infection.
Meanwhile, the University of Oxford and AstraZeneca have become the first COVID-19 vaccine manufacturers to publish end-stage clinical trial results in a scientific journal, removing a key obstacle in the global drug production race safe and effective for the novel coronavirus.
US President-elect Joe Biden laid out his plan to tackle the coronavirus pandemic in his first 100 days in office, saying his administration would vaccinate 100 million Americans, push to reopen schools and strengthen mask mandates .
Here are the latest updates:
Ukraine reports daily coronavirus deaths
Ukraine’s daily coronavirus death toll rose to 276 from the previous record of 257 deaths recorded in November, Health Minister Maksym Stepanov said.
He also said 12,585 new cases of the coronavirus had been registered in the past 24 hours, bringing the total to 845,343 cases with 14,204 deaths.
Mnuchin says he presented Pelosi with $ 916 billion relief proposal
U.S. Treasury Secretary Steven Mnuchin said he had presented a $ 916 billion coronavirus relief proposal that includes money for state and local governments and liability protections for them. companies in a conversation with Democratic House of Representatives Speaker Nancy Pelosi on Tuesday.
“As part of this proposal, we will fund it using $ 140 billion in unused paycheck protection program funds and $ 429 billion in treasury funds,” Mnuchin said.
United Arab Emirates Says Sinopharm Vaccine Has 86% Effectiveness
The UAE’s health ministry said an interim analysis of the country’s phase three clinical trials of Sinopharm’s COVID-19 vaccine has an 86% effectiveness against the infection.
He also said he registered the Chinese vaccine, for which he approved emergency use in September for some groups. The ministry statement provided few details, but marked the first public disclosure of information on the effectiveness of the shooting.
The United Arab Emirates conducted a vaccine trial starting in September by Chinese state-owned pharmaceutical giant Sinopharm, involving 31,000 volunteers from 125 countries. Volunteers between the ages of 18 and 60 received two doses of the vaccine for 28 days.